Number of Shares
9,201.00
Current Holdings Value*
$44,200.00
% of Portfolio
0.01%
Total Estimate Gain
$1.05 Mil
% of Total Estimate Gain
10.63%

Baron Global Advantage Fund's Viking Therapeutics Inc Holding Summary

As of 2025-03-31, BARON SELECT FUNDS held 9,201.00 shares of Viking Therapeutics Inc(VKTX), totaling $44,200.00. This investment constitutes 0.01% of their stock portfolio, and BARON SELECT FUNDS now holds 0.01% of the outstanding Viking Therapeutics Inc(VKTX) stock.

The initial trade took place in 2024Q1. And since then Baron Global Advantage Fund has made 2 purchases of VKTX, at an average price of $44.37, for a total of 222,645.00 shares. In addition, there have been 2 sales at an average price of $49.82 for 213,444.00 shares. Based on historical transaction data and VKTX's current price of $32.01, Baron Global Advantage Fund's estimated gain on his VKTX holdings is $1.05 Mil, reflecting a 10.63% gain to date.

Baron Global Advantage Fund VKTX ($32.01) Holding Chart

Baron Global Advantage Fund VKTX ($32.01) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1